Portrait of Crist, Charlie Joseph

Crist, Charlie Joseph

U.S. Representative FL-13 Democratic Party

Congressional stock trade history disclosed under the STOCK Act, as filed.

Disclosed trades
12
Buys / sells
17% / 83%
Last trade
Mar 1, 2017
Last filing
Mar 23, 2017

Latest disclosed trades

Latest 10 of 12
Ticker Type Traded
NVG Buy Mar 1, 2017
BCE Sell Feb 22, 2017
WMT Sell Feb 22, 2017
LUV Sell Feb 22, 2017
T Sell Feb 22, 2017
MSFT Sell Feb 22, 2017
GM Sell Feb 22, 2017
GSK Sell Feb 22, 2017
AAPL Sell Feb 22, 2017
SUN Sell Feb 22, 2017

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window.

Crist, Charlie Joseph stock trade activity

FilingIQ has indexed 12 congressional stock trade disclosures for Crist, Charlie Joseph. The most recent disclosed transaction is dated Mar 1, 2017.

Across the full history, 2 purchases and 10 sales have been disclosed under the STOCK Act.

Top tickers traded by Crist, Charlie Joseph

Frequently asked

How many stock trades has Crist, Charlie Joseph disclosed?
FilingIQ tracks 12 Periodic Transaction Report disclosures for Crist, Charlie Joseph, with the most recent dated Mar 1, 2017. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Crist, Charlie Joseph a net buyer or net seller?
Across the disclosed trade history, 2 (17%) were purchases and 10 (83%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Crist, Charlie Joseph come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.